GE HealthCare Announces Changes in Strategic Leadership and Key Segments

GE HealthCare has announced the appointment of Roland Rott as president and CEO of Imaging and Phil Rackliffe as president and CEO of Ultrasound and Image Guided Therapies (IGT), effective July 1, 2024. Roland, who joined GE HealthCare in 2011, has held several leadership positions within Ultrasound, culminating in his role as president and CEO in 2021. Phil, who joined GE HealthCare in 2022, has successfully led the IGT division, significantly contributing to its revenue growth during his tenure.

In the third quarter of 2024, GE HealthCare plans to merge the IGT segment, a $1.6 billion subsegment of Imaging, with its Ultrasound segment. This merger will create a global business with over $5.0 billion in annual revenue, enhancing GE HealthCare’s agility and ability to meet future imaging needs in both inpatient and outpatient settings. Even without IGT, the Imaging segment will remain GE HealthCare’s largest, generating more than $8.9 billion annually. This restructuring will allow the Imaging segment to focus more on surgical and interventional solutions, particularly in interventional cardiology and structural heart procedures, while maintaining Ultrasound’s leadership in diagnostics.

Peter Arduini, CEO of GE HealthCare, expressed confidence in the new appointments, highlighting the fresh perspectives, global insights, and deep industry expertise that Roland and Phil will bring to their roles. He emphasized that their understanding of customer needs, market trends, and strategic focus would accelerate innovation and growth within the company. Arduini praised both leaders as well-positioned to drive GE HealthCare’s precision care strategy and deliver exceptional outcomes for patients and customers.

en_GBEnglish (UK)